Explore the latest in PCI, including evolving indications, technologies, and use of antiplatelet agents to maximize efficacy and safety.
This cohort study examines the extent to which disparities in access, treatment, and outcomes have changed for patients with ST-segment elevation myocardial infarction (STEMI) who are living in zip codes that are largely composed of Black or Hispanic individuals compared with patients in nonminority communities in regionalized vs nonregionalized counties.
This cohort study assesses adherence to evidence-based fractional flow reserve (FFR) thresholds for percutaneous coronary intervention in Canada between 2013 and 2018, and associations of percutaneous coronary intervention with major adverse clinical outcomes for patients with FFR measures above and beneath ischemic thresholds.
This cohort study describes temporal trends and institutional variations of multivessel percutaneous coronary intervention use for ST-elevation myocardial infarction in the United States between 2009 and 2018.
This case-control study assess the association of US False Claims Act investigations of the overuse of PCIs with PCI volumes.
This cohort study examines the potential implications of the ISCHEMIA trial on the appropriateness of percutaneous coronary intervention in patients with stable ischemic heart disease.
This cohort study compares net risk for ischemic vs hemorrhagic events at 12 months among patients treated with ticagrelor vs clopidogrel during and after percutaneous coronary intervention (PCI) management of acute coronary syndrome (ACS).
This meta-analysis evaluates the difference in all-cause and cause-specific mortality in randomized clinical trials comparing percutaneous coronary intervention with coronary artery bypass grafting for the treatment of patients with coronary artery disease.
This case report describes a patient with coronavirus disease 2019 who developed late drug-eluting stent thrombosis.
This cohort study examines the association of pretreatment with P2Y12 receptor antagonist with 30-day and 1-year mortality and in-hospital bleeding among patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS).
This cohort study evaluates patterns in the use of multivessel vs culprit-vessel percutaneous coronary intervention in acute myocardial infarction and cardiogenic shock in the US from 2009 to 2018.
This cohort study investigates the extent to which post–percutaneous coronary intervention (PCI) fractional flow reserve (FFR) mediates the association of pre-PCI FFR with vessel-related outcomes using an international, multicenter collaboration registry.
This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis.
This case report presents the electrocardiographic findings of a man in his 60s with progressive dyspnea and substernal chest discomfort at rest following placement of a single drug-eluting stent.
This open-label randomized trial compares the effect of a genotype-guided oral P2Y12 inhibitor selection strategy vs conventional clopidogrel prescribing on 12-month ischemic outcomes after percutaneous coronary intervention (PCI) in CYP2C19*2/CYP2C19*3 loss-of-function allele carriers with acute coronary syndromes and stable cardiovascular disease.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: